LMR 2

Yves Laure Pimentel · 70問 · 2年前

通報

問題一覧

: reaction rate is dependent on enzyme concentration only

ZERO-ORDER KINETICS

: reaction rate is directly proportional to substrate concentration

FIRST-ORDER KINETICS

: thickening or hardening of the walls of arteries

Arteriosclerosis

: accumulation of lipid in the veins and arteries

Atherosclerosis

: elevated urea in blood

Azotemia

: deficiency of adrenocortical hormones

Addison’s disease

: aldosterone-secreting adrenal adenoma

Conn’s syndrome

excessive production of glucocorticoids (cortisol) by adrenal cortex

Cushing’s syndrome:

: tumors of the adrenal medulla or symphatetic ganglia that produce and release large quantities of catecholamines

Phaeochromocytoma

: cessation of menstruation

Amenorrhea

: Greek work YELLOW; irreversible scarring process by which normal liver architecture is transformed into abnormal nodular architecture

Cirrhosis

Cirrhosis: Greek work ?; irreversible scarring process by which normal liver architecture is transformed into abnormal nodular architecture

YELLOW

: hereditary disorder in which there is DECREASED BILIRUBIN TRANSPORT into the hepatocytes.

Gilbert’s syndrome

Gilbert’s syndrome: hereditary disorder in which there is ? TRANSPORT into the hepatocytes.

DECREASED BILIRUBIN

: hereditary DEFICIENCY of the UDPG-TRANSFERASE ENZYME

Crigler-Najjar syndrome

Crigler-Najjar syndrome: hereditary DEFICIENCY of the ?

UDPG-TRANSFERASE ENZYME

is associated with increased plasma conjugated bilirubin, inborn error of metabolism

Dubin-Johnson syndrome

, possibly of viral origin, where there is also a block in the excretion of conjugated bilirubin but without liver pigmentation

Rotor syndrome

is a defect of copper transport from the liver resulting in overload of copper in liver and brain

Wilson’s disease

is an X-linked recessive disorder in which defective transport of copper from mucosal cells results in copper deficiency.

Menkes disease

Menkes disease is an X-linked recessive disorder in which defective transport of copper from mucosal cells results in ? deficiency.

copper

Menkes disease is an ? disorder in which defective transport of copper from mucosal cells results in copper deficiency.

X-linked recessive

: chronic autoimmune thyroiditis; it is the most common cause of primary hypothyroidism

Hashimoto’s thyroiditis

Hashimoto’s thyroiditis: chronic autoimmune thyroiditis; it is the most common cause of ? hypothyroidism

primary

: diffuse toxic goiter

Graves’ disease

: acute protein calories malnutrition

Kwashiorkor

: caused by caloric insufficiency without protein insufficiency so that the serum albumin level remains normal; there is considerable loss of body weigh

Marasmus

: cells of the testicles that produce testosterone

Leydig cells

Leydig cells: cells of the testicles that produce ?

testosterone

: cell membrane marker of stem cells

CD34

GRANULAR, DIRTY, BROWN CASTS representing hemoglobin degradation products such as methemoglobin:

ACUTE TUBULAR NECROSIS

GRANULAR, DIRTY, BROWN CASTS representing hemoglobin degradation products such as ?: ACUTE TUBULAR NECROSIS

methemoglobin

: Providing an antibody with its corresponding antigen under optimal conditions so that the antibody will attach to the antigen, thereby removing the antibody from the serum

ADSORPTION

: process whereby cells that are coated with antibody are treated in such a manner as to disrupt the bonds between the antigen and antibody

ELUTION

: red blood cell enzyme used as an identification marker in paternity testing and criminal investigation (Harmening)

ALKALINE PHOSPHATASE (ALP)

: gene that does not appear to produce a detectable antigen; a silent gene

AMORPH

: connection between two blood vessels, either direct or through connecting channels

ANASTOMOSIS

: DOLICHOS BIFLORUS

ANTI-A1 LECTIN

ANTI-A1 LECTIN:

DOLICHOS BIFLORUS

: BANDEIRAEA SIMPLICIFOLIA

ANTI-B LECTIN

ANTI-B LECTIN:

BANDEIRAEA SIMPLICIFOLIA

: ULEX EUROPAEUS

ANTI-H LECTIN

ANTI-H LECTIN:

ULEX EUROPAEUS

: IBERIS AMARA

ANTI-M LECTIN

ANTI-M LECTIN:

IBERIS AMARA

: VICIA GRAMINEA

ANTI-N LECTIN

ANTI-N LECTIN:

VICIA GRAMINEA

: phenomenon whereby an antibody reacts more strongly with a red blood cell carrying a double dose (homozygous inheritance of the appropriate gene) than with a red blood cell carrying a single dose (heterozygous inheritance) of an antigen

DOSAGE

: portion of the antigen molecule that is directly involved in the interaction with the antibody; the ANTIGENIC DETERMINANT

EPITOPE

EPITOPE: portion of the antigen molecule that is directly involved in the interaction with the antibody; the ?

ANTIGENIC DETERMINANT

: antigenic characteristic of the red blood cell membrane that is unique to an individual or a related family of individuals and therefore is not commonly found on all cells (usually less than 1% of the population)

PRIVATE ANTIGEN

PRIVATE ANTIGEN : antigenic characteristic of the red blood cell membrane that is unique to an individual or a related family of individuals and therefore is not commonly found on all cells (usually ? of the population)

less than 1%

: antigen characteristic of the red blood cell membrane found commonly among individuals, usually more than 98% of the population

PUBLIC ANTIGEN

PUBLIC ANTIGEN: antigen characteristic of the red blood cell membrane found commonly among individuals, usually ? of the population

more than 98%

: programmed cell death

Apoptosis

: small hemorrhagic spot, LARGER THAN PETECHIA, in the skin or mucous membrane, forming a rounded or irregular blue or purplish patch; also known as bruise

Ecchymosis

Ecchymosis : small hemorrhagic spot, LARGER THAN PETECHIA, in the skin or mucous membrane, forming a rounded or irregular blue or purplish patch; also known as ?

bruise

: fingernails are thin, flattened and concave; associated with iron deficiency anemia

Koilonychia

Koilonychia: fingernails are thin, flattened and concave; associated with

iron deficiency anemia

: thin, flat red cell with hemoglobin at periphery and increased central pallor; hypochromic cell

Leptocyte

Leptocyte: thin, flat red cell with hemoglobin at periphery and increased central pallor; ? cell

hypochromic

Reed-Sternberg cell: presence is definitive histologic diagnosis of

HODGKIN’S DISEASE

: presence is definitive histologic diagnosis of HODGKIN’S DISEASE

Reed-Sternberg cell

: leukocytes of the myelocytic series, and sometimes all leukocytes contain coarse azurophilic mucopolysccharide granules

Alder-Reilly anomaly

: needle-shaped or round inclusion in the cytoplasm of myeloblasts and promyelocytes; composed of condensed primary granules

Auer rod

: congenital, autosomal recessive disorder, characterized by partial albinism, photophobia and the presence of abnormally large blue granules in leukocytes

Chediak-Higashi anomaly

: autosomal dominant inherited blood cell disorder characterized by thrombocytopenia and granules containing cytoplasmic inclusions similar to Dohle bodies

May-Hegglin anomaly

May-Hegglin anomaly: ? inherited blood cell disorder characterized by thrombocytopenia and granules containing cytoplasmic inclusions similar to Dohle bodies

autosomal dominant

Chediak-Higashi anomaly: congenital, ? disorder, characterized by partial albinism, photophobia and the presence of abnormally large blue granules in leukocytes

autosomal recessive

: cutaneous T CELL LYMPHOMA characterized by exfoliative erythroderma, peripheral lymphadenopathy and ? cells present in the skin, lymph nodes and peripheral blood

Sezary syndrome

Sezary syndrome: cutaneous ? characterized by exfoliative erythroderma, peripheral lymphadenopathy and Sezary cells present in the skin, lymph nodes and peripheral blood

T CELL LYMPHOMA

: rare disorder of fat metabolism caused by deficiency of glucocerebrosidase

Gaucher’s disease

Gaucher’s disease: rare disorder of fat metabolism caused by deficiency of

glucocerebrosidase

: mutations to platelet GP IB or GP IX, defect of platelet adhesion

Bernard-Soulier syndrome

: mutations to platelet GP IIb or IIIa; defect of fibrinogen-dependent platelet aggregation

Glanzmann’s thrombasthenia

: protein produced by the neutrophis and stored in the secondary granules that is able bind iron

Lactoferrin

: basic pipet

GLASS PIPET

SAMPLES for glucose testing and for other assays are used frequently in many health care facilities for bedside testing, or point-of-care testing (POCT)

CAPILLARY BLOOD

: hormone produced by the hypothalamus to regulate water reabsorption in the COLLECTING DUCT

ANTIDIURETIC HORMONE

ANTIDIURETIC HORMONE : hormone produced by the hypothalamus to regulate water reabsorption in the ?

COLLECTING DUCT

?: regulates flow of blood to and within the kidneys by responding to changes in blood pressure and plasma sodium content

RENIN-ANGIOTENSIN-ALDOSTERONE SYSTEM

: BLACK, TARRY STOOL associated with gastrointestinal hemorrhage

MELENA

MELENA: BLACK, TARRY STOOL associated with

gastrointestinal hemorrhage

MELENA: ? STOOL associated with gastrointestinal hemorrhage

BLACK, TARRY STOOL

STOOL: pancreatic disorder, bile-duct obstruction

BULKY/FROTHY

BULKY/FROTHY STOOL: DSE

pancreatic disorder, bile-duct obstruction

STOOL: intestinal constriction

RIBBON-LIKE

RIBBON-LIKE STOOL: DSE

intestinal constriction

COLOR STOOL: upper GI bleeding, iron therapy, charcoal, BISMUTH (antacids)

BLACK

: absence of sperm in a semen sample

AZOOSPERMIA

: low sperm count

OLIGOSPERMIA

: immature spermatozoa

SPERMATIDS

: Part of the germinal epithelium of the seminiferous tubules, give rise to spermatozoa

SERTOLI CELLS

: cells of the testicles that produce testosterone

LEYDIG CELLS

: tip of a spermatozoa head, which contains enzymes for entry into an ovum

ACROSOMAL CAP

PROTEIN ERROR OF INDICATORS: color-change phenomenon occurring because PROTEINS ACT AS ? AT A CONSTANT PH

HYDROGEN ION ACCEPTORS

: color-change phenomenon occurring because PROTEINS ACT AS HYDROGEN ION ACCEPTORS AT A CONSTANT PH

PROTEIN ERROR OF INDICATORS

: abrupt change in the mean of a series of results

SHIFT

: gradual change in one direction of the mean of a control substance

TREND

100

: step-by-step documentation of the handling and testing of legal specimens

CHAIN OF CUSTODY

other names parasitology

other names parasitology

70問 • 2年前

Yves Laure Pimentel · 111問 · 2年前

PARASITOLOGY

PARASITOLOGY

111問 • 2年前

Yves Laure Pimentel · 64問 · 2年前

HTMLBE

HTMLBE

64問 • 2年前

Yves Laure Pimentel · 61問 · 2年前

CC - 1 LAB. SAFETY, BASIC UNITS, AND CONVERSION FACTOR

CC - 1 LAB. SAFETY, BASIC UNITS, AND CONVERSION FACTOR

61問 • 2年前

Yves Laure Pimentel · 69問 · 2年前

HISTOPATHOLOGY

HISTOPATHOLOGY

69問 • 2年前

CC-2 SPECTROPHOTOMETRY

CC-2 SPECTROPHOTOMETRY

Yves Laure Pimentel · 41問 · 2年前

CC-3 ELECTROPHORESIS

CC-3 ELECTROPHORESIS

41問 • 2年前

Yves Laure Pimentel · 87問 · 2年前

AUBF LAB SAFETY

AUBF LAB SAFETY

87問 • 2年前

CSF 1

CSF 1

Yves Laure Pimentel · 82問 · 2年前

CSF 2

CSF 2

82問 • 2年前

SEMEN 1

SEMEN 1

Yves Laure Pimentel · 7問 · 2年前

SEMEN 2

SEMEN 2

7問 • 2年前

SYNOVIAL FLUID 1

SYNOVIAL FLUID 1

Yves Laure Pimentel · 6問 · 2年前

SYNOVIAL FLUID 2

SYNOVIAL FLUID 2

6問 • 2年前

Yves Laure Pimentel · 25問 · 2年前

SEROUS FLUID

SEROUS FLUID

25問 • 2年前

Yves Laure Pimentel · 44問 · 2年前

PLEURAL FLUID

PLEURAL FLUID

44問 • 2年前

Yves Laure Pimentel · 18問 · 2年前

PERICARDIAL FLUID

PERICARDIAL FLUID

18問 • 2年前

Yves Laure Pimentel · 30問 · 2年前

PERITONEAL FLUID/ ASCITIC FLUID

PERITONEAL FLUID/ ASCITIC FLUID

30問 • 2年前

Yves Laure Pimentel · 92問 · 2年前

AMNIOTIC FLUID

AMNIOTIC FLUID

92問 • 2年前

Yves Laure Pimentel · 80問 · 2年前

FECALYSIS

FECALYSIS

80問 • 2年前

Yves Laure Pimentel · 89問 · 2年前

OTHER BODY FLUIDS

OTHER BODY FLUIDS

89問 • 2年前

Yves Laure Pimentel · 86問 · 2年前

MTLBE- SUHO NOTES

MTLBE- SUHO NOTES

86問 • 2年前

Yves Laure Pimentel · 35問 · 2年前

MTLBE..

MTLBE..

35問 • 2年前

Yves Laure Pimentel · 19問 · 1年前

CC- CHROMATOGRAPHY

CC- CHROMATOGRAPHY

19問 • 1年前

Yves Laure Pimentel · 14問 · 1年前

CC-OSMOMETRY

CC-OSMOMETRY

14問 • 1年前

Yves Laure Pimentel · 43問 · 1年前

CC-ELECTROCHEMISTRY TECHNIQUES

CC-ELECTROCHEMISTRY TECHNIQUES

43問 • 1年前

Yves Laure Pimentel · 49問 · 2年前

CC- CARBOHYDRATES

CC- CARBOHYDRATES

49問 • 2年前

Yves Laure Pimentel · 97問 · 2年前

CC- DIABETES MELLITUS

CC- DIABETES MELLITUS

97問 • 2年前

Yves Laure Pimentel · 57問 · 2年前

MAJOR LIPOPROTEINS

MAJOR LIPOPROTEINS

57問 • 2年前

Yves Laure Pimentel · 63問 · 2年前

MINOR LIPOPROTEINS

MINOR LIPOPROTEINS

63問 • 2年前

Yves Laure Pimentel · 37問 · 2年前

PROTEINS

PROTEINS

37問 • 2年前

Yves Laure Pimentel · 91問 · 2年前

PLASMA PROTEINS 1

PLASMA PROTEINS 1

91問 • 2年前

Yves Laure Pimentel · 98問 · 2年前

PLASMA PROTEINS 2 (ALPHA 2 REGION)

PLASMA PROTEINS 2 (ALPHA 2 REGION)

98問 • 2年前

Yves Laure Pimentel · 61問 · 2年前

MISCELLANEOUS PROTEINS

MISCELLANEOUS PROTEINS

61問 • 2年前

Liver Function Test 1

Liver Function Test 1

Yves Laure Pimentel · 96問 · 2年前

Liver Function Test 2

Liver Function Test 2

96問 • 2年前

Yves Laure Pimentel · 33問 · 2年前

TUMOR MARKERS

TUMOR MARKERS

33問 • 2年前

Yves Laure Pimentel · 41問 · 2年前

KIDNEY FUNCTION TESTS - NON PROTEIN NITROGEN & CREATININE

KIDNEY FUNCTION TESTS - NON PROTEIN NITROGEN & CREATININE

41問 • 2年前

Yves Laure Pimentel · 17問 · 2年前

GLYCOGEN STORAGE DISEASES

GLYCOGEN STORAGE DISEASES

17問 • 2年前

Yves Laure Pimentel · 14問 · 2年前

LIPID STORAGE DISEASES

LIPID STORAGE DISEASES

14問 • 2年前

Yves Laure Pimentel · 71問 · 2年前

PROTEINS

PROTEINS

71問 • 2年前

Yves Laure Pimentel · 7問 · 2年前

QUICK FIRE- ELECTRODES

QUICK FIRE- ELECTRODES

7問 • 2年前

Yves Laure Pimentel · 10問 · 2年前

ELECTROLYTES

ELECTROLYTES

10問 • 2年前

Yves Laure Pimentel · 27問 · 2年前

DRUGS

DRUGS

27問 • 2年前

Yves Laure Pimentel · 12問 · 2年前

TOXIC AGENTS:

TOXIC AGENTS:

12問 • 2年前

HEMATOLOGY 1 (HEMATOPOIESIS 1)

HEMATOLOGY 1 (HEMATOPOIESIS 1)

Yves Laure Pimentel · 29問 · 2年前

HEMATOLOGY (HEMATOPOIESIS 2)

HEMATOLOGY (HEMATOPOIESIS 2)

29問 • 2年前

Yves Laure Pimentel · 25問 · 2年前

hema diseases

hema diseases

25問 • 2年前

Yves Laure Pimentel · 43問 · 2年前

AML

AML

43問 • 2年前

Yves Laure Pimentel · 71問 · 2年前

GLOBIN SYNTHESIS

GLOBIN SYNTHESIS

71問 • 2年前

Yves Laure Pimentel · 31問 · 2年前

HEMATOLOGY REFERENCE RANGES

HEMATOLOGY REFERENCE RANGES

31問 • 2年前

Yves Laure Pimentel · 34問 · 2年前

DISORDERS OF PRIMARY HEMOSTASIS

DISORDERS OF PRIMARY HEMOSTASIS

34問 • 2年前

Yves Laure Pimentel · 37問 · 2年前

PLATELET DISORDERS

PLATELET DISORDERS

37問 • 2年前

CHARACTERISTICS OF CLOTTING FACTORS

CHARACTERISTICS OF CLOTTING FACTORS

Yves Laure Pimentel · 12問 · 2年前

4. CLASSIFICATION OF MACROPHAGE

4. CLASSIFICATION OF MACROPHAGE

12問 • 2年前

Yves Laure Pimentel · 39問 · 2年前

3. NATURAL OR INNATE IMMUNITY

3. NATURAL OR INNATE IMMUNITY

39問 • 2年前

Yves Laure Pimentel · 55問 · 2年前

5. INTERNAL DEFENSE:SOLUBLE FACTORS (ACUTE PHASE REACTANTS)

5. INTERNAL DEFENSE:SOLUBLE FACTORS (ACUTE PHASE REACTANTS)

55問 • 2年前

Yves Laure Pimentel · 37問 · 2年前

6. PHAGOCYTOSIS Chemotaxis

6. PHAGOCYTOSIS Chemotaxis

37問 • 2年前

Yves Laure Pimentel · 44問 · 2年前

8. NATURE OF ANTIGEN

8. NATURE OF ANTIGEN

44問 • 2年前

Yves Laure Pimentel · 50問 · 2年前

9. MAJOR HISTOCOMPATIBILITY COMPLEX/HUMAN LEUKOCYTE ANTIGEN

9. MAJOR HISTOCOMPATIBILITY COMPLEX/HUMAN LEUKOCYTE ANTIGEN

50問 • 2年前

Yves Laure Pimentel · 69問 · 2年前

1. HISTORY

1. HISTORY

69問 • 2年前

Yves Laure Pimentel · 38問 · 2年前

2. TYPES OF IMMUNITY

2. TYPES OF IMMUNITY

38問 • 2年前

Yves Laure Pimentel · 21問 · 2年前

7. PHAGOCYTOSIS Engulfment and Digestion

7. PHAGOCYTOSIS Engulfment and Digestion

21問 • 2年前

Yves Laure Pimentel · 15問 · 2年前

8. PHAGOCYTOSIS EXOCYTOSIS

8. PHAGOCYTOSIS EXOCYTOSIS

15問 • 2年前

Yves Laure Pimentel · 32問 · 2年前

10. DISEASE ASSOCIATED TO HUMAN LEUKOCYTE ANTIGEN (henry)

10. DISEASE ASSOCIATED TO HUMAN LEUKOCYTE ANTIGEN (henry)

32問 • 2年前

Yves Laure Pimentel · 30問 · 2年前

11. TRANSPLANTATION IMMUNOLOGY

11. TRANSPLANTATION IMMUNOLOGY

30問 • 2年前

Yves Laure Pimentel · 38問 · 2年前

2. LYMPHOID ORGANS

2. LYMPHOID ORGANS

38問 • 2年前

Yves Laure Pimentel · 48問 · 2年前

3. CLUSTER OF DIFFERENTIATION

3. CLUSTER OF DIFFERENTIATION

48問 • 2年前

Yves Laure Pimentel · 35問 · 2年前

4. T-CELL DIFFERENTIATION

4. T-CELL DIFFERENTIATION

35問 • 2年前

Yves Laure Pimentel · 18問 · 2年前

5. T CELL IMMUNODEFICIENCIES

5. T CELL IMMUNODEFICIENCIES

18問 • 2年前

Yves Laure Pimentel · 44問 · 2年前

6. STAGES IN B-CELL DIFFERENTIATION  PROPIMAP

6. STAGES IN B-CELL DIFFERENTIATION  PROPIMAP

44問 • 2年前

Yves Laure Pimentel · 23問 · 2年前

7. B CELL IMMUNODEFICIENCIES

7. B CELL IMMUNODEFICIENCIES

23問 • 2年前

Yves Laure Pimentel · 34問 · 2年前

8. COMBINED T CELL AND B CELL DEFICIENCIES

8. COMBINED T CELL AND B CELL DEFICIENCIES

34問 • 2年前

Yves Laure Pimentel · 12問 · 2年前

9. COMPARISON OF T AND B CELLS

9. COMPARISON OF T AND B CELLS

12問 • 2年前

Yves Laure Pimentel · 16問 · 2年前

10. LABORATORY IDENTIFICATION OF LYMPHOCYTES

10. LABORATORY IDENTIFICATION OF LYMPHOCYTES

16問 • 2年前

Yves Laure Pimentel · 15問 · 2年前

11. NATURAL KILLER CELLS OR THIRD POPULATION CELL

11. NATURAL KILLER CELLS OR THIRD POPULATION CELL

15問 • 2年前

Yves Laure Pimentel · 79問 · 2年前

12. ANTIBODY

12. ANTIBODY

79問 • 2年前

Yves Laure Pimentel · 97問 · 2年前

13. TYPES OF ANTIBODIES

13. TYPES OF ANTIBODIES

97問 • 2年前

Yves Laure Pimentel · 11問 · 2年前

14. MONOCLONAL ANTIBODIES

14. MONOCLONAL ANTIBODIES

11問 • 2年前

Yves Laure Pimentel · 23問 · 2年前

1. INTERLEUKINS

1. INTERLEUKINS

23問 • 2年前

Yves Laure Pimentel · 28問 · 2年前

2. INTERFERONS

2. INTERFERONS

28問 • 2年前

Yves Laure Pimentel · 8問 · 2年前

3. CYTOKINES IN THE INNATE AND ADAPTIVE IMMUNITY

3. CYTOKINES IN THE INNATE AND ADAPTIVE IMMUNITY

8問 • 2年前

Yves Laure Pimentel · 19問 · 2年前

4. COMPLEMENT SYSTEM

4. COMPLEMENT SYSTEM

19問 • 2年前

Yves Laure Pimentel · 76問 · 2年前

15. COMPLEMENT SYSTEM

15. COMPLEMENT SYSTEM

76問 • 2年前

Yves Laure Pimentel · 21問 · 2年前

16. SYSTEM CONTROLS/COMPLEMENT REGULATION

16. SYSTEM CONTROLS/COMPLEMENT REGULATION

21問 • 2年前

Yves Laure Pimentel · 29問 · 2年前

17. COMPLEMENT AND DISEASE STATES

17. COMPLEMENT AND DISEASE STATES

29問 • 2年前

Yves Laure Pimentel · 19問 · 2年前

18. IMMUNOLOGIC ASSAYS OF INDIVIDUAL COMPONENTS (CLASSICAL)

18. IMMUNOLOGIC ASSAYS OF INDIVIDUAL COMPONENTS (CLASSICAL)

19問 • 2年前

Yves Laure Pimentel · 22問 · 2年前

19. CYTOKINES

19. CYTOKINES

22問 • 2年前

Yves Laure Pimentel · 24問 · 2年前

20. INTERLEUKINS

20. INTERLEUKINS

24問 • 2年前

Yves Laure Pimentel · 21問 · 2年前

21. INTERFERONS, TNF, TGF, CHEMOKINE

21. INTERFERONS, TNF, TGF, CHEMOKINE

21問 • 2年前

Yves Laure Pimentel · 54問 · 2年前

1. SERO

1. SERO

54問 • 2年前

Yves Laure Pimentel · 38問 · 2年前

2. PRECIPITATION

2. PRECIPITATION

38問 • 2年前

Yves Laure Pimentel · 17問 · 2年前

3. PASSIVE IMMUNODIFFUSION

3. PASSIVE IMMUNODIFFUSION

17問 • 2年前

Yves Laure Pimentel · 15問 · 2年前

4. OUCHTERLONY

4. OUCHTERLONY

15問 • 2年前

Yves Laure Pimentel · 9問 · 2年前

5. ELECTROPHORETIC TECHNIQUE

5. ELECTROPHORETIC TECHNIQUE

9問 • 2年前

Yves Laure Pimentel · 11問 · 2年前

6. IMMUNOELECTROPHORESIS (DOUBLE DIFFUSION)

6. IMMUNOELECTROPHORESIS (DOUBLE DIFFUSION)

11問 • 2年前

Yves Laure Pimentel · 29問 · 2年前

7. IMMUNOFIXATION ELECTROPHORESIS

7. IMMUNOFIXATION ELECTROPHORESIS

29問 • 2年前